Critical evaluation of current Alzheimer’s drug discovery (2018–19) & futuristic Alzheimer drug model approach-Reference-Cited by-同舟云学术

Critical evaluation of current Alzheimer’s drug discovery (2018–19) & futuristic Alzheimer drug model approach

Published:2019-12 Issue: Volume:93 Page:103299
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Dorababu Atukuri

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference321 articles.

1. Alzheimer’s disease;Burns;BMJ,2009

2. Alzheimer's disease;Ballard;Lancet,2011

3. Alzheimer's disease;Querfurth;N. Engl. J. Med.,2010

4. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study;GBD 2015 Disease Injury Incidence Prevalence Collaborators (October 2016);Lancet,2015

5. Genome-wide association studies in Alzheimer disease;Waring;Arch. Neurol.,2008

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selenylated Analogs of Tacrine: Synthesis, In Silico and In Vitro Studies of Toxicology and Antioxidant Properties;Chemistry – An Asian Journal;2024-09-03

2. Evaluating the Neuroprotective Potential of Novel Benzodioxole Derivatives in Parkinson’s Disease via AMPA Receptor Modulation;ACS Chemical Neuroscience;2024-05-15

3. Carbamate as a potential anti‐Alzheimer's pharmacophore: A review;Drug Development Research;2023-09-11

4. An ongoing journey of chalcone analogues as single and multi-target ligands in the field of Alzheimer's disease: A review with structural aspects;Life Sciences;2023-05

5. Colony-stimulating factor 1 receptor signaling in the central nervous system and the potential of its pharmacological inhibitors to halt the progression of neurological disorders;Inflammopharmacology;2022-03-15